In terms of the atherosclerotic process, it would be appropriate to analyze the impact of evolocumab on the vascular NO signaling pathway, especially on endothelial and inducible NOS, which would have a greater informative value in relation to atherosclerosis. The gene discussed is NOS2; the disease is atherosclerosis.